Acute myelomonocytic leukemia presenting as a benign-appearing cutaneous eruption [PDF]
Cole, John T. +3 more
core +1 more source
Characterization of genetically modified human embryonic kidney 293 cells lacking equilibrative nucleoside transporter subtype 2, or both subtypes 1 and 2, and the impact of their loss on sensitivity to chemotherapeutic purine/pyrimidine analogs. [PDF]
Shahid N, Hammond JR.
europepmc +1 more source
Is thioguanine-associated sinusoidal obstruction syndrome avoidable? Lessons learned from 6-thioguanine treatment of inflammatory bowel disease and a mouse model [PDF]
Duley, John A. +4 more
core
dECM-Supported Printing of Plasmonic Pillars for SERS Monitoring of Chemotherapy in 3D Tumor Models. [PDF]
Troncoso-Afonso L +8 more
europepmc +1 more source
Determining variant effects with pooled prime editing. [PDF]
Kajba CM, Herger M.
europepmc +1 more source
Using pharmacogenomics to personalise drug therapy: which drugs, when and how. [PDF]
Stocker SL, Polasek TM.
europepmc +1 more source
The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients. [PDF]
Crouwel F +10 more
europepmc +1 more source
Nucleobase catalysts for the enzymatic activation of 8-oxoguanine DNA glycosylase 1. [PDF]
Hank EC +31 more
europepmc +1 more source
All-component-active metal-organic frameworks for tailored chemoradiotherapy of self-defensive tumors. [PDF]
Xu X +6 more
europepmc +1 more source
Adsorption of drugs on B12N12 and Al12N12 nanocages. [PDF]
Geetha Sadasivan Nair R +2 more
europepmc +1 more source

